Venus Remedies Ltd - VENUS REMEDIES Share Price

Sector: Pharmaceuticals | ISIN: INE411B01019
₹ 240.10 (-3.22%) icon4 Oct, 2023, 3:14:36 PM

Venus Remedies Ltd Stock View

info icon
Edit Image
STRONG BUY
Target | 31 May, 2023 200 (-16.84%)

Venus Remedies Ltd is a research-based pharmaceutical company. The Company is a global injectable manufacturer, possessing a wide product basket catering to therapeutic segments of anti-infe... Read More

Venus Remedies Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 10/4/2023 3:14:36 PM

    ₹ 240.1 -8.00 -3.22
  • Open
  • ₹ 251.05
  • Prev. Close
  • ₹ 248.1
  • Turnover(Lac.)
  • ₹ 58
  • Day's High
  • ₹ 251.25
  • Day's Low
  • ₹ 235.3
  • 52 Week's High
  • ₹ 300
  • 52 Week's Low
  • ₹ 145.8
  • Book Value
  • ₹ 360.88
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 320.94
  • P/E
  • 15.24
  • EPS
  • 16.62
  • Divi. Yield
  • 0

Venus Remedies Ltd Corporate Actions

15 Jul , 2023

12:00 AM

AGM

Announcement date: 15 Jul , 2023

View Details

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

05 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jan , 2023

12:00 AM

02 Nov , 2022

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2023

12:00 AM

BookCloser

View Details

Venus Remedies Ltd News and Update

Image not found
  • 1 day ago |
  • 8:41 PM

According to a statement from Coal India Ltd (CIL), the total volume of coal delivered was 1.8 MT more than the 293 MT demand anticipated for this time period.

Image not found
Image not found
  • IIFL News Service |
  • 26 September, 2023 |
  • 8:31 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Venus Remedies Ltd SHAREHOLDING SNAPSHOT
04 October , 2023 | 03:14 PM

PROMOTER - TOTAL41.76%

Indian: 41.76%

Foreign: 0%

NON-PROMOTER - TOTAL 58.24%

Institutions: 1.13%

Non-Institutions: 57.11%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Venus Remedies Ltd FINANCIALS

Venus Remedies Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Venus Remedies Ltd

  • Pawan Chaudhary
  • Chairman & Managing Director
  • Manu Chaudhary
  • Joint Managing Director
  • Peeyush Jain
  • Deputy Managing Director
  • Ashutosh Jain
  • Executive Director
  • Gilbert Wenzel
  • Independent Director
  • S. K. Chadha
  • Independent Director
  • Neha Kodan
  • Company Sec. & Compli. Officer
  • Navdeep Sud
  • Independent Director
  • Savita Gupta
  • Independent Director
  • Akshansh Chaudhary
  • Whole-time Director
  • NPS Monga
  • Additional Director

Summary

Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril.The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as WHO-GMP as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc.In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and... Read More


Reports by Venus Remedies Ltd


Reports by Venus Remedies Ltd

Company FAQ

No Record Found